Ticker Scorecard - KRON Basics Company: Kronos Bio, Inc. IPO Date: October 9, 2020 Sector: Healthcare Industry: Biotech Market Cap: $59.79M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 3.68% Avg Daily Range (30 D): $0.02 | 2.34% Avg Daily Range (90 D): $0.02 | 2.55% Institutional Daily Volume Avg Daily Volume: .22M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 469 Avg Trade Size (Sh.) (90 D): 395 Institutional Trades Total Inst.Trades: 177 Avg Inst. Trade: $2.57M Avg Inst. Trade (30 D): $1.19M Avg Inst. Trade (90 D): $1.19M Avg Inst. Trade Volume: .2M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.68M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 320.38K     News Oct 23, 2024 @ 12:55 PM Kronos Bio Data Presentation at EORTC-NCI-AACR Sym... Source: N/A Oct 7, 2024 @ 12:55 PM Kronos Bio Announces Selection of Autoimmune Devel... Source: N/A Aug 8, 2024 @ 9:45 PM 10x Genomics (TXG) Reports Q2 Loss, Tops Revenue E... Source: N/A May 23, 2024 @ 9:15 PM Kronos Bio to Present Clinical Update on Phase 1/2... Source: Kronos Bio, Inc. May 22, 2024 @ 8:30 PM Kronos Bio to Participate in Three Upcoming Health... Source: Kronos Bio, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.43 $-.23 $-.27 Diluted EPS $-1.43 $-.23 $-.27 Revenue $ 9.86M $ 2.37M $ 2.69M Gross Profit $ $ $ Net Income / Loss $ -85.59M $ -14.11M $ -16.2M Operating Income / Loss $ -93.08M $ -15.72M $ -18.02M Cost of Revenue $ $ $ Net Cash Flow $ 17.37M $ 4.76M $ 5.88M PE Ratio